<i>Mycobacterium abscessus</i>and Children with Cystic Fibrosis
Isabelle Sermet‐Gaudelus(Hôpital Necker-Enfants Malades), Jean‐Louis Gaillard(Hôpital Raymond-Poincaré)
Cited by 159
Related Papers
Modulators of CFTR. Updates on clinical development and future directions
|European Journal of Medicinal Chemistry|2021|67
CFTR: New insights into structure and function and implications for modulation by small molecules
|Journal of Cystic Fibrosis|2019|20
Volatile metabolites differentiate air–liquid interface cultures after infection with <i>Staphylococcus aureus</i>
|The Analyst|2023|13
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy
|Clinical Pharmacokinetics|2024|10
“Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective
|Journal of Cystic Fibrosis|2021|6